Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 

SEC Filings

Filing date Form Description Filing Group View
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML
S-8

Securities offered to employees pursuant to employee benefit plans

Registration Statements
View HTML
SC 13G/A

An amendment to the SC 13G filing

3,4,5
View HTML
SC 13G/A

An amendment to the SC 13G filing

3,4,5
View HTML
SC 13G/A

An amendment to the SC 13G filing

3,4,5
View HTML